|
|
|
|
E-022 / E-022-1ML updated item number format
EDDP perchlorate
1.0 mg/mL (as pyrrolinium) in Methanol | Certified Reference Material
|
|
A certified Snap-N-Spike® solution of the major urinary metabolite of methadone. Methadone, sold under various trade names such as Symoron, Amidone or Methadose, is a synthetic opioid used medically as an analgesic and as a maintenance anti-addictive for use in patients with opioid dependency. Suitable uses for this reference standard include as starting material in preparation of calibrators and controls for LC/MS or GC/MS methods in methadone testing for applications in clinical toxicology or forensic analysis.
|
|
|
|
|
| Concentration:
|
1.0 mg/mL (as pyrrolinium)
|
| Solvent:
|
Methanol
|
| Unit Size:
|
1 mL/ampoule
|
| CAS Number:
|
31161-17-8
|
| Chemical Formula:
|
C20H24N · ClO4
|
| Molecular Weight:
|
377.86
|
| Certificate of Analysis:
|
|
| US List Price:
|
|
|
|
***Promotional Pricing Applied in Shopping Cart***
|
|
| E-006 / E-006-10MG |
|
EDDP perchlorate,10 mg (as salt)
|
|
$89.00
|
|
|
|
|
|
| E-021 / E-021-1ML |
|
EDDP-D3 perchlorate (Methadone metabolite), 100 μg/mL (as pyrrolinium)
|
|
$40.70
|
|
|
|
|
|
| E-057 / E-057-1ML |
|
EMDP HCl, 1.0 mg/mL (as free base)
|
|
$161.00
|
|
|
|
|
|
| E-062 / E-062-1ML |
|
EDDP-D3 perchlorate, 1.0 mg/mL (as pyrrolinium)
|
|
$234.00
|
|
|
|
|
|
| M-007 / M-007-1ML |
|
(±)-Methadone, 1.0 mg/mL
|
|
$28.20
|
|
|
|
|
|
| M-008 / M-008-1ML |
|
(±)-Methadone-D3, 100 μg/mL
|
|
$40.70
|
|
|
|
|
|
| M-021 / M-021-1ML |
|
(±)-Methadone-D3, 1.0 mg/mL
|
|
$156.00
|
|
|
|
|
|
| M-088 / M-088-1ML |
|
(±)-Methadone-D9, 100 μg/mL
|
|
$39.10
|
|
|
|
|
|
| M-089 / M-089-1ML |
|
(±)-Methadone-D9, 1.0 mg/mL
|
|
$156.00
|
|
|
|
|
|
| O-020 / O-020-1ML |
|
Opiate Multi-Component Mixture-5, 250 μg/mL of each component
|
|
$167.00
|
|
|
|
|
|
| P-071 / P-071-1ML |
|
Pain Management Multi-Component Opiate Mixture-13, 100 μg/mL of each component; 10 μg/mL of Fentanyl
|
|
$449.00
|
|
|
|
|
|
▶ Depletion of Phospholipid Matrix Interferences when Dealing with Small Volume Plasma Samples | Craig Aurand, David Bell, and Hillel Brandes, Supelco, 2010
|
|
▶ Direct Analysis of Urinary Opioids and Metabolites by Mixed-Mode µElution SPE Combined with UPLC/MS/MS for Forensic Toxicology | Jonathan P. Danaceau, Erin E. Chambers, and Kenneth J. Fountain, Waters, 2013
|
|
▶ High Throughput Screening and confirmation of 41 Pain Panel Drugs in Oral Fluid by an Integrated On-Line Extraction UHPLC-MS/MS System | Louis Maljers, Zicheng Yang, Bruker Daltonics Inc, 2016
|
|
▶ Proof of Concept for Automated SPE/HPLC/MS/MS Methods to Replace Traditional Immunoassay with MS Confirmation of Driving Under the Influence Samples | Robert M. Sears, Toxicology Technical Leader , Kenneth Lewis, CEO , and Kim Gamble, President, ITSP Solutions, INC., 2014
|
|
▶ Rapid Differentiation of Isobaric Drugs Using a Novel Direct Sample Analysis Source, CID, and Accurate Mass TOF Mass Spectrometry | Robert J. Seward, Bonnie Marmor, and Andrew Tyler, PerkinElmer, Inc., 2014
|
|
▶ Testing and Quantitation of Opioids in Urine and Serum by LC-TOF | Sharanya Reddy, Nonnie Danna, PerkinElmer Inc,, 2014
|
|
▶ Ultrafast Analysis of Methadone and Metabolite EDDP in Urine by the Agilent RapidFire High-Throughput Mass Spectrometry System | Mohamed Youssef and Vaughn P. Miller, Agilent Technologies, Inc., 2012
|
|
▶ Utilizing Novel SPME LC Tips for Forensic Screening of Drugs of Abuse in Urine Samples | Sigma-Aldrich®, 2015
|
|
|
|
|